ProCE Banner Series

CCO Official Conference Coverage of HIVR4P 2024

Join us for a live, interactive webinar as global expert faculty provide a rapid update on HIV prevention strategies from the recent HIVR4P conference and answer your questions. 

  AMA
Who Should Attend

This program is intended for physicians and other healthcare professionals who care for people at risk of HIV acquisition.

All Events

CCO Official Conference Coverage of HIVR4P 2024

Past Events

October

14

2024

2:00 PM - 3:00 PM Eastern Time (ET)

Virtual

October

15

2024

12:00 PM - 1:00 PM Eastern Time (ET)

Virtual

Faculty

ProCE Banner Faculty
Linda-Gail Bekker, MBChB, DTMH, DCH, FCP(SA), PhD

Director and Professor, The Desmond Tutu HIV Centre, UCT
CEO, The Desmond Tutu Health Foundation
Cape Town, South Africa

ProCE Banner Faculty
Meredith E. Clement, MD

Associate Professor of Medicine
Section of Infectious Diseases
Louisiana State University Health Sciences Center-New Orleans
New Orleans, Louisiana

ProCE Banner Faculty
Beatriz Grinsztejn, MD, PhD

Director of the STI/AIDS Clinical Research Laboratory
Evandro Chagas National Institute of Infectious Diseases
FIOCRUZ
Rio de Janeiro, Brazil

ProCE Banner Faculty
Raphael J. Landovitz, MD, MSC

Professor of Medicine
Division of Infectious Diseases
David Geffen School of Medicine/University of California
Director
UCLA Center for Clinical AIDS Research and Education (CARE)
Co-Director
Center for HIV Identification, Prevention, and Treatment Services (CHIPTS)
Los Angeles, California

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
The goal of this program is to improve the knowledge and competence of learners in applying new findings to optimize strategies to prevent HIV acquisition.

Target Audience
This program is intended for physicians and other healthcare professionals who care for people at risk of HIV acquisition.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Devise HIV prevention strategies based on the results of recent clinical studies

  • Integrate the latest scientific findings on strategies to overcome major barriers to wider uptake of HIV prevention interventions 

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CME Passport

662be69741e7b.png

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC in partnership with the International AIDS Society  

Supported by educational grants from Gilead Sciences, Inc. and ViiV Healthcare.